Questions and answers about the Cancer Screening Research Network (CSRN) are grouped into 6 categories and are available on individual pages:
- General Application FAQs
- ACCrual, Enrollment, and Screening Sites (ACCESS) Hub FAQs
- Coordinating and Communication Center (CCC) FAQs
- Statistics and Data Management Center (SDMC) FAQs
- Types of Studies FAQs
- Vanguard Study FAQs
For additional questions, please contact CSRN@nih.gov.
Relevant Links
Multi-Cancer Detection Notices
- NOT-CA-23-055: NCI Virtual Workshop to Engage Multi-Cancer Detection (MCD) Assay Developers
- NOT-CA-22-033: Seeking Input from Multi-Cancer Early Detection Test Developers on Readiness for Participation in an NCI-Sponsored Clinical Utility Randomized Controlled Screening Trial
CSRN Requests for Applications (RFAs)
- RFA-CA-23-020: Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub
- RFA-CA-23-021: Cancer Screening Research Network: Statistics and Data Management Center
- RFA-CA-23-022: Cancer Screening Research Network: Coordinating and Communication Center
Multi-Cancer Detection (MCD) Research
This webpage is a gateway to DCP efforts surrounding study of MCD assays for cancer screening.
Last updated: 02/21/2023